Hemogenyx Pharmaceuticals (HEMO)

Sector:

Pharma and Biotech

337.00p
   
  • Change Today:
    -1.50p
  • 52 Week High: 1,342.00
  • 52 Week Low: 320.00
  • Currency: UK Pounds
  • Shares Issued: 3.60m
  • Volume: 11,028
  • Market Cap: £12.15m
  • RiskGrade: 340

Latest Deals

No deals were found in the last 365 days.

Largest Deals (365 days)

No deals were found in the last 365 days.

Director Shareholdings

Notifier Holding Value*
Alexis M. Sandler 187,727 £632,640
Vladislav Sandler Ph.D. 103,862 £350,015
Peter Redmond 13,991 £47,150

Major Shareholders

Notifier** Holding Value*
Alexis Sandler 187,727 £632,640
Dr Vladislav Sandler 103,862 £350,015
Optiva Securities Limited 70,329 £237,009
Flascherberg Capital Anstalt 69,991 £235,870
Craig Auringer 59,593 £200,828
HSBC Client Holdings Nominee (UK) Limited 45,160 £152,189
Ron Valk 42,828 £144,330
Samantha Bauer 42,706 £143,919
Plum Capital 29,232 £98,512
43 North LLC 28,429 £95,806
Abdelatif LACHAB 6,500 £21,905
Wayne Gibson 6,500 £21,905

* Value is calculated by using the current share price multiplied by the amount held.
** Major Shareholders are individuals or institutions that own more than 3% of the company’s shares and have been reported in the annual accounts.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

HEMO Market Data

Currency UK Pounds
Share Price 337.00p
Change Today -1.50p
% Change -0.44 %
52 Week High 1,342.00
52 Week Low 320.00
Volume 11,028
Shares Issued 3.60m
Market Cap £12.15m
RiskGrade 340

HEMO Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
44.23% below the market average44.23% below the market average44.23% below the market average44.23% below the market average44.23% below the market average
50% below the sector average50% below the sector average50% below the sector average50% below the sector average50% below the sector average
Price Trend
86.12% below the market average86.12% below the market average86.12% below the market average86.12% below the market average86.12% below the market average
71.43% below the sector average71.43% below the sector average71.43% below the sector average71.43% below the sector average71.43% below the sector average
Income Not Available
Growth Not Available

HEMO Dividends

No dividends found

Trades for 14-Feb-2025

Time Volume / Share Price
16:23 259 @ 327.23p
15:59 312 @ 327.23p
15:57 88 @ 331.61p
15:18 29 @ 339.00p
13:34 293 @ 327.24p

HEMO Key Personnel

CEO Vladislav Sandler Ph.D.

Top of Page